PAMELA REAMER: Open Payments
NPI 1831382878 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,363 in 72 payments from 21 companies in 2025. Trend: 2023 $1,749 · 2024 $2,007 · 2025 $1,363
Food & beverage: $1,363
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $274 |
| Novo Nordisk Inc | 8 | $186 |
| AstraZeneca Pharmaceuticals LP | 7 | $171 |
| Lilly USA, LLC | 9 | $143 |
| Axsome Therapeutics, Inc. | 5 | $100 |
| GlaxoSmithKline, LLC. | 4 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| Phathom Pharmaceuticals, Inc. | 3 | $53 |
| Abbott Laboratories | 2 | $39 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $26 |
Products named: VRAYLAR, AIRSUPRA, Auvelity, Wegovy, Ozempic, Kerendia, QULIPTA, ZEPBOUND.
Industry payments across NY — which companies pay providers there.
